Max Robotics — Global Service Robot Directory + US Certification

About

Gianpiero Catalano is a leading figure in the evolving landscape of prostate cancer management, with a focused expertise in stereotactic radiotherapy and the surgical treatment of prostate malignancies. His most cited work, a 2009 study on linac-based or robotic image-guided stereotactic radiotherapy for isolated lymph node recurrent prostate cancer (71 citations), established a critical benchmark for non-invasive salvage treatments, demonstrating how precision radiation can effectively target oligorecurrent disease. This contribution has influenced clinical protocols for managing post-prostatectomy recurrence, offering patients a less morbid alternative to traditional therapies. Catalano also provides vital insights into surgical trends, as evidenced by his comparative analysis of radical prostatectomy procedures in Italy over the last decade, a study drawing on data from over 1,500 patients in the MIRROR-SIU/LUNA and Pros-IT CNR registries. By documenting the shift toward minimally invasive techniques, his work helps surgeons and patients understand the real-world evolution of prostate cancer care. With a career bridging advanced radiotherapy and surgical outcomes, Catalano’s research continues to shape both the technical and practical dimensions of prostate cancer treatment.